Acute lymphoblastic leukaemia trials in Iran

2 of 2 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  Safety and Efficacy of CAR T Cell Therapy in Patients with R/r B-ALL

  Where

  Tehran

  Age

  2 years to 18 years

  People

  5

  Run by

  Kara Yakhteh Tajhiz Azma Company

  See details and how to joinNCT06635330
• Phase 1/2Not yet taking people in Iran
  Cell Therapy with Anti-CD19 CAR-NK Cells in Patients with Relapsed or Resistant B-ALL

  Where

  Tabriz

  Age

  3 years and over

  People

  10

  Run by

  Shahid Beheshti University of Medical Sciences

  See details and how to joinNCT06631040